Protalix Biotherapeutics Inc. (PLX) Attracts A Huge Investment By A Large Hedge Fund

Highbridge Capital Management disclosed a 5.3% brand new stake in medical research company Protalix Biotherapeutics Inc. (NYSE:PLX).

Keep Reading →